SELECTBIO is pleased to welcome you to Cell Therapy Asia 2018 which will be held in Kobe, Japan.
This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application.
The conference addresses the whole ecosystem of Cell Therapy and Tissue Engineering with a focus on 3D-Culture, Organoids, Microfluidics technologies for constructing microphysiological systems.
In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.
With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell Therapy Asia 2018.
SELECTBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference and invites young scientists to submit poster abstracts to the conference. From these poster abstracts, the scientific leadership team of the conference will pick outstanding abstracts for oral presentations.
- 3D-Bioprinting and Tissue Engineering
- 3D-Culture and Organoids
- Clinical Trials and Commercialization of Cell Therapies
- Cord Blood and Cord Blood-Derived Stem Cells for Cellular Therapy
- Emerging Technologies and Emerging Companies Showcase
- iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
- Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
- Microfluidics Platforms
- Stem Cells for Cellular Therapy
Confirmed Speakers to date
Shizuka Akieda, Chief Executive Officer, Cyfuse Biomedical K.K.
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Tatsuo Heki, Senior Expert, Regenerative Medicine Division, Fujifilm Corporation
Shin-Il Kim, Director, Division of Research & Development, aceRNA Technologies Co., Ltd.
Thasaneeya Kuboki, Assistant Professor, Laboratory of Biomedical and Biophysical Chemistry, Institute for Materials Chemistry and Engineering, Kyushu University
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Hirofumi Suemori, Associate Professor, Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
William G Whitford, Strategic Solutions Leader Bioprocess, GE Healthcare Life Sciences